Menu

YS Biopharma Co., Ltd. YS

Full chart Compare
Set alert

Price alert · YS

All alert types
1.02 0.00 (+0.00%)

At closeMay 24, 2024, 4:00 PM EDT

0.90 Day range 1.10

52-week range unavailable

Revenue & Expenses

Income Tax Benefit → Expenses: $946.87KExpenses → Selling, General & Admin: $390.73MExpenses → Research & Development: $146.37MExpenses → Other Operating Expenses: $56.38MExpenses → Other Expenses: $14.64MGross Profit → Expenses: $507.19MRevenue → Gross Profit: $507.19MRevenue → Cost of Revenue: $107.77MNet Loss → Expenses: $99.98MIncome Tax Benefit$946.87KGross Profit$507.19MNet Loss$99.98MCost of Revenue$107.77MExpenses$608.12MSelling, General & Admin$390.73MResearch & Development$146.37MOther Operating Expenses$56.38MOther Expenses$14.64MRevenue$614.96M

Latest period ending Mar 31, 2023 · select a line to chart its full history

Annual income statement

YS annual income statement
Fiscal yearFY 2023 Mar 31, 2023FY 2022 Mar 31, 2022FY 2021 Mar 31, 2021
687.20M502.95M257.02M
687.20M502.95M257.02M
153.36M117.07M59.66M
533.84M385.88M197.36M
673.22M504.84M323.21M
318.70M211.22M94.39M
354.52M293.62M228.82M
-139.38M-118.96M-125.85M
30.86M2.72M29.69M
1.13M4.94M17.45M
-283.47M-236.67M-208.44M
-421.46M-367.33M-225.05M
-421.46M-367.33M-225.05M
-145.48M-106.00M-191.83M
137.99M130.66M16.61M
-1.56-1.71-3.10
-1.56-1.71-3.10
-1.56-1.71-3.10
-251.48M-229.01M-161.29M
-251.48M-229.01M-161.29M
137.99M130.66M16.61M
93.06M61.83M61.83M
93.06M61.83M61.83M